Related Experiment Video
Updated: May 13, 2025
07:56
A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts
Published on: February 17, 2023
844
Anions, Membrane Resistance and Ventricular Fibrillation.
Journal of Basic and Clinical Physiology and Pharmacology
|April 15, 2025
Summary
Preventing sudden cardiac death, often caused by ventricular fibrillation (VF), requires new strategies. This research explores manipulating chloride homeostasis and altering sarcolemmal membrane resistance as novel approaches to suppress VF.
Area of Science:
- Cardiovascular Research
- Electrophysiology
- Cellular Physiology
Background:
- Sudden cardiac death (SCD) prevention remains a significant clinical challenge.
- Ventricular fibrillation (VF) is a primary cause of SCD, necessitating improved preventative measures.
Purpose of the Study:
- To review data supporting novel approaches for VF prevention.
- To investigate the potential of chloride homeostasis manipulation for VF suppression.
Main Methods:
- Review of existing data on chloride homeostasis and cardiac electrophysiology.
- Analysis of studies focusing on sarcolemmal membrane resistance.
- Exploration of novel therapeutic targets for VF prevention.
Main Results:
- Data suggest that manipulating chloride homeostasis can prevent VF.
- Alteration of sarcolemmal membrane resistance presents a novel strategy for VF suppression.
Conclusions:
- Modulating chloride homeostasis offers a promising avenue for preventing VF.
- Targeting sarcolemmal membrane resistance represents a new approach to suppress life-threatening arrhythmias.
Related Concept Videos
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
832
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
832
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
704
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
704
01:30Cardiac Action Potential
599
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
599
01:26Voltage-gated Ion Channels
7.8K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
7.8K
01:19Electrophysiology of Normal Cardiac Rhythm
1.8K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
1.8K